The effect of rapamycin on TGFβ1 and MMP1 expression in a rabbit model of urethral stricture

S L Huang1, D L Fu1, H C Li1

  • 1Department of Urology, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an City, 710004, Shaanxi Province, People's Republic of China.

Abstract

Insights

Rapamycin reduced fibrosis in a rabbit urethral stricture model. It increased matrix metalloproteinase-1 (MMP1) but did not affect transforming growth factor-beta 1 (TGFβ1) levels.

Area of Science:

  • Urology
  • Pharmacology
  • Biochemistry

Background:

  • Urethral stricture is a significant cause of morbidity.
  • Fibrosis and collagen deposition are key pathological features.
  • Investigating novel therapeutic targets is crucial for treatment.

Purpose of the Study:

  • To evaluate the therapeutic potential of rapamycin in a rabbit model of urethral stricture.
  • To determine the effect of rapamycin on transforming growth factor-beta 1 (TGFβ1) and matrix metalloproteinase-1 (MMP1) expression.

Main Methods:

  • A rabbit model of urethral stricture was established via electrocoagulation.
  • Rabbits were randomized into three groups: normal saline, dimethyl sulfoxide (vehicle), and rapamycin.
  • Histological, qRT-PCR, and immunohistochemical analyses were performed on urethral tissues.

Main Results:

  • Rapamycin treatment significantly reduced fibrosis and collagen deposition compared to control groups.
  • MMP1 mRNA and protein expression were significantly upregulated by rapamycin.
  • No significant changes in TGFβ1 mRNA or protein levels were observed with rapamycin treatment.

Conclusions:

  • Rapamycin demonstrates antifibrotic effects in a rabbit urethral stricture model.
  • The antifibrotic mechanism involves upregulation of MMP1 expression.
  • Rapamycin does not directly influence TGFβ1 expression in this model.

Related Concept Videos